|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-9-15
|
|
pubmed:abstractText |
The effects of the gonadotropin releasing hormone (GnRH) agonist (D-Trp(6)) were examined in two human ovarian cancer cell lines and in severe combined immune deficiency (SCID) mice to evaluate its potential as a cytocidal, cytostatic, or differentiating antitumor agent.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 1999 Academic Press.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
170-80
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10419728-Animals,
pubmed-meshheading:10419728-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10419728-Apoptosis,
pubmed-meshheading:10419728-CDC2 Protein Kinase,
pubmed-meshheading:10419728-Carcinoma,
pubmed-meshheading:10419728-Cell Cycle,
pubmed-meshheading:10419728-Cell Differentiation,
pubmed-meshheading:10419728-Female,
pubmed-meshheading:10419728-Mice,
pubmed-meshheading:10419728-Mice, SCID,
pubmed-meshheading:10419728-Ovarian Neoplasms,
pubmed-meshheading:10419728-Triptorelin Pamoate,
pubmed-meshheading:10419728-Tumor Cells, Cultured
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Antitumor effect of GnRH agonist in epithelial ovarian cancer.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, St. Vincent's Hospital, Suwon, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
